Ab­b­Vie, No­vo Nordisk TV ads gen­er­ate most search­es in first half of 2022, ad track­er finds

Most phar­ma TV com­mer­cials in­clude a link at the end of the ad, of­fer­ing a web­site link for view­ers who want more in­for­ma­tion. It turns out mil­lions of them do. So far in 2022, Ab­b­Vie, No­vo Nordisk and As­traZeneca are lead­ing the phar­ma pack with the most en­gage­ments gar­nered, ac­cord­ing to da­ta for the first half of 2022 from TV ad track­er EDO.

Ab­b­Vie’s Al­ler­gan Vuity eye­drops for age-re­lat­ed blur­ry vi­sion drove the most search­es among phar­ma TV ad­ver­tis­ing, gen­er­at­ing 3.43 mil­lion search­es af­ter ad runs. That’s more than dou­ble the to­tal for the next searched TV ad at No. 2, No­vo Nordisk’s Ozem­pic, which notched 1.7 mil­lion, in EDO’s re­search.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER